BioMr. Gregg is a Special Investment Partner with Galen Partners. Mr. Gregg currently is the President & CEO of DexCom, Inc. In 2002 he retired as President of Medtronic MiniMed, a world leader in diabetes management systems and a portfolio company of Galen II. He became President and Chief Operating Officer of MiniMed Inc in 1996 and was instrumental in Medtronic’s $3.4 billion acquisition of MiniMed in 2001. He also ....
Education